GSE104352
SMAD2/3 binding pattern in triple-negative breast cancer cell lines, Hs578T and BT549  [ChIP-seq]
SMAD2 and SMAD3 have diverse binding profiles in triple-negative breast cancer cell lines. Overall design: SMAD2/3 ChIP-seq analyses were performed in 2 different TNBCs at 2 different time points after TGFß treatment.